Abstract: It is well established that CCl 4 induce liver injury in animals through
INTRODUCTION
Liver as the body's key organ of metabolism and excretion is continuously and variedly exposed to xenobiotics which makes it highly susceptible to their adverse and toxic effects. Toxins absorbed from the GI tract gain access first to the liver resulting in a variety of liver disease. Thus liver damage or hepatotoxicity ranges from acute hepatitis to hepatocellular carcinoma, through apoptosis, necrosis, inflammation, immune response, fibrosis, ischemia, altered gene expression and regeneration [1] . Variability in drug metabolism among human as well as differences in CYP450 expression, have been reported. Genetic polymorphisms, endocrine imbalance, poor diet, and environmental factors can influence the expression of CYP450s in normal human livers. Occurrence of one or more of these factors can predispose a patient to altered CYP450 metabolism and unwanted/negative consequences associated with standard doses of a drug [2] [3] . Carbon tetrachloride (CCl 4 ) has been widely used to experimentally induce liver injury in rodents and to examine the pathogenesis of cirrhosis. An acute dose of CCl 4 causes centrizonal, necrosis and steatosis [4] , while chronic administration causes liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC) [5] . CCl 4 mechanism impairs hepatocytes directly due to altering permeability of the plasma, lysosomal, and mitochondrial membranes. Also, highly reactive free radical metabolites are formed by the mixed function oxidase system in hepatocytes via CYP2E1, causing severe centrilobular necrosis [6] . Studies showed that reactive oxygen species (ROS) are causative factors of degenerative diseases, including some hepatopathies [7] . The over-production of ROS and therefore oxidative stress can be initiated by a variety of xenobiotics, such as acetaminophen and carbon tetrachloride (CCl 4 ) [8] . CCl 4 induces hepatotoxic effect via its reductive dehalogenation by CYP450 2E1 to the highly reactive trichloromethyl radical (•CCl 3 ), which is subsequently converted into a trichloromethylperoxyl radical (•OOCCl 3 ) in the presence of oxygen [4] .
The extracts of the flowers and leaves of silybum marianum have been used for centuries in treating liver or spleen along with gallbladder diseases [9] .The extract consists of about 65-80% silymarin and 20-35% fatty acids, including linoleic acid [10] . Most clinical studies were carried out with isolated silymarin and flavonolignon [11] . The safety of S. marianum herbal plant is one of the most important issues, since no health hazards or side effects are known along with the proper treatment of designed therapeutic dosages [12] . The most important derivative of silybin is silymarin (70-80%) and their antiradical and antioxidant activity was studied by [13] . Silymarin shows the antioxidant, antiinflammatory; and anticarcinogenic properties [14] . The molecular targets of silymarin for cancer prevention is modulate the balance between cell survival and apoptosis through interference with cell cycle regulators and proteins involved in apoptosis [15] .
The Silybum marianum, have an antioxidant and have been shown to exhibit anti carcinogenic, antiinflammatory, hepatoprotection and growth modulatory effects. [16] Due mainly to their diverse pharmacological properties including antioxidant and hepatoprotective activity. [17] Plant-derived natural products such as flavonoids, terpenoids, carbohydrates, tannins, saponins, steroids, proteins, amino acids and vitamin have received considerable attention [18] [19] . Few literatures concerning aqueous extract Silybum marianum, so that, the effect of aqueous extract of silybum marianum (SB) plant relative to silymarin (SM) as standard drug against CCl 4 induced liver damage is evaluated in this present study.
MATERIALS AND METHODS

Animals
Male Sprague-Dawley rats initially weighing (180-200g) were obtained from the Institute of Ophthalmic Disease Research, Cairo, Egypt. They were housed in stainless steel cages in an artificially illuminated and thermally controlled room (22-25°C and 12 h light / dark cycle). Rats were fed on normal laboratory rodent diet and given water ad libitum for one week of acclimation prior to the experimental work. All animals received human care in compliance with the guidelines of the Animal Care and Use Committee of Mansoura University.
Silymarin Standard Drug
Each capsule (140mg) dissolved in 5ml distilled water.
Preparation of Silybum Marianum Aqueous Extracts
SB seeds were purchased from a local market in Mansoura City, Egypt. And extraction was performed as described by [20].
Detection of Total Phenolic Compounds in Aqueous Extract of Silybum Marianum and in Silymarin Standard Drug
Total phenolic content of aqueous crude extract of silybum marianum and silymarine standard drug was determined by Folin-Ciocalteu method [21].
Experimental Protocol
Thirty six adult male rats were allocated to one of six groups of six rats of each and subjected to the following treatments:
Control (G1) served as control and received 500μl of saline by intraperitoneal (i.p.) injection route twice a week for 4 weeks. 
Semi-Quantitative RT-PCR Of CYP450
To determine the effects of aqueous extract SB and SM drug on hepatic cytochrome P450 at gene level, semi-quantitative RT-PCR was determined. The specific oligonucleotide primers were shown in Table 1 . Briefly, total RNA was extracted from tissue with TRIzol reagent according to the manufacturer's instructions (Invitrogen Corporation, Grand Island, NY, USA). Reverse transcription was done using 1 μg of total RNA and a cDNAkit (high-capacity cDNA archive kit, USA). Two μl of the cDNA sample was mixed with 25 picoMole of each primer and 12.5μl of Taq PCR (master mix kit, QIAGEN Inc, Valencia, CA, USA). Distilled water was added to a volume of 25μl, and the resulting mixture was subjected to PCR amplification (BioRad Thermal Cycler, USA). The cycling parameters were as follows: initial denaturation at 95°C for 5 minutes, followed by 30 cycles of 95°C for 30 seconds, annealing at 58°C for 30 seconds, elongation at 72°C for 30 seconds, and final extension at 72°C for 10 minutes. The resulting products were electrophoresed in a 1% agarose gel to detect gene bands. The signal intensity of the bands was measured using BioRad Gel Documentation model (universal hood2, USA) software and the changes in expression were normalized to GAPDH control. 
Table1. The primer sequences used for real time PCR assay in rats
Histopathological Examination
The liver tissues, fixed in 10% formalin, was dehydrated through the ascending series of ethyl alcohol (50-100), cleared in xylene, infiltrated and embedded in paraffin wax. Transverse sections of liver were cut at thickness of 5 µm and stained with Mayer's Haematoxylin and Eosin (H&E) stains for microscopic examination and atomic force microscope (AFM).according to [34].
Atomic Force Microscope (AFM) Image
AFM imaging was conducted in Nanotechnology center, Mansoura University, Mansoura, Egypt. Stiffness of the liver tissue was carried according to the method of [35] . The AFM imaging was conducted using contact mode using uncoated sharpend microlevers and sharpend tip with 10nm radius NANOSUR FLEX AFM (NANOSURF AG, SWITZERLAND). For an AFM probe, silicon cantilever with spring constant of 0.2N/m.scans were performed in air.
Statistical Analysis
All values are presented as mean ±SEM. Differences were considered to be significant at p<0.05. One-way analysis of variance (ANOVA) and post-hoc test were used to determine differences between groups. 
RESULTS
The results of biochemical parameters demonstrated that the rats treated with CCl 4 caused significant (P≤0.05) peroxidative damage as evidenced by liver enzymes and antioxidant defense system (table 2, 3). In contrast, administration of aqueous extract of SB to CCl 4 treated rats (G4), showed a significant decrease (P≤0.05) in liver MDA, while GST, GSH, SOD, CAT, and TAC activity were significantly increased (P≤0.05) as compared to CCl 4 treated rats (G2). Also, administration of standard SM to CCl 4 treated rats (G3) showed a significant decrease (P≤0.05) in liver MDA, while GST, GSH, SOD, CAT, and TAC activity were significantly increased (P≤0.05) as compared to CCl 4 treated rats (G2). Moreover, administration of aqueous extract of SB to treated rats with CCl 4 (G4) shows significant increase (P≤0.05) in GST activity while it did not show any significant change in liver MDA level or liver GST, SOD, CAT, and TAC activity when compared with G3.
Table2. Serum alanine transaminase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP) enzyme activity and albumin concentration (ALB) in control group and in different rat groups
Groups ALT (U/L) AST (U/L) ALP (U/L) Albumin (g/dl) G1
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Semi-Quantitative RT-PCR Of Cytochrome P450
CCl 4 is a hepatotoxic chemical that requires phase I drug metabolizing enzymes for metabolic activation. Therefore, it was important to determine the effects of aqueous extract of SB on the activity of CYP450 enzyme, so that the expression of this cytochrome was performed using semiquantitative RT-PCR of in liver. As shown in Figure ( 1) CYP450 was significantly (P≤0.05) increase in CYP 450 in CCl 4 treated rats (G2) in comparison with the control group (G1). However, administration of aqueous extract of SB to CCl 4 treated rats (G4), significantly (P≤0.05) decrease in CYP450 when compared with CCl 4 treated rats (G2). Also, when SM standard was administered to CCl 4 treated rats (G3), significantly (P≤0.05) decrease in the level of CYP450 enzyme when compared with the CCl 4 treated rats (G2). Moreover, the results revealed that there is non significant changes when comparing the group that treated with aqueous extract of SB (G4) group with the standard SM treated group (G3).
Fig1. Reverse Transcription -Polymerase Chain Reactions (RT-PCR) of P450 gene illustrates the relative expression percentages of different samples relative to negative control (100%) by measuring the intensity of bands in agarose gel electrophoresis (semi-quantitative) by BioRad Gel Documentation model (Universal hood2, USA).
A histpathological study of liver sections of normal control (G1) rats revealed normal liver architecturenormal hepatocytes as shown in Figure (2B) . Liver of CCl 4 treated rats (G2) showed marked fatty change with vacuolization of hepatocytes and scattered inflammatory cells with mild fibrosis. Microscopically, examination of liver sections of rats pretreated with the aqueous extract of SB(G4) in a daily dose 200 mg/kg b.wt. For6 weeks in combination with CCl 4 decrease the severity of histopathological changes induced by CCl 4 .The liver showed mild fatty change, mild fibrosis, and inflammation( Figure 2C ). The liver of pretreated rats with SMin combination with CCl 4 (G3)showed less fatty changes with congested veins and few inflammatory cells with no fibrosis( Figure  2D ).While, histopathological examination of livers of aqueous extract of SB pretreated rats (G6) revealed normal hepatocytes (arrow) with normal radial arrangement around central vein( Figure 2E ). Histopathological examination of livers of SM standard drug (G5) revealed showing normal hepatocytes (arrow) with normal radial arrangement around central vein ( Figure 2F ).
Fig2. Photomicrographs of histological sections of rat liver. A. Control showing normal liver architecture, normal hepatocytes (HE, 200x). B: CCl 4 treated rats showing marked fatty change with vacuolization of hepatocytes, and scattered inflammatory cells, with mild fibrosis (HE, 200x).C: silymarine standard drug with CCl 4 treatment showing less fatty changes with congested veins and few inflammatory cells with no fibrosis (HE, 200x). D: silybium with CCl 4 treatment showing mild fatty changes, mild fibrosis, and inflammation .E: silymarine standard drug showing normal hepatocytes (arrow) with normal radial arrangement around central vein (HE, 400x).F: silybium marianum showing normal hepatocytes (arrow) with normal radial arrangement around central vein (HE, 400x).
(a) 
DISCUSSION
The main model to induce liver injury in animal is the administration of CCl 3 is metabolized by CYP2E1 in liver cells to produce trichloromethyl radical, trichloromethylperoxyl radical and ROS, which can cause liver damage and increase the production of fibrotic tissue [55] [56] .On the other hand, the results of the present study demonstrated that CYP450 was significantly normalized in the liver of treated rats with aqueous extract of SB compared with normal control. These results indicated that the restoration of CYP450 after SB treatment may be due to their regulation of CYP450 through anti-oxidative effect to affect the metabolism function of liver.
There are a number of natural hepatic protectors out there [57], but silybum marianum has shown more promise when it comes to supporting hepatic injury. Previous studies indicated the antioxidant properties of silybum marianum retarding and inhibiting the process of lipid peroxidation [58] . They reported that silybum marianum enhances hepatic glutathione and may contribute to the antioxidant defense of the liver. It has also been shown that it increases protein synthesis in hepatocytes by stimulating RNA polymerase I activity. Silybum marianum had a potent antioxidant effect due to scavenging of free radicals, superoxide anions, and oxygen radicals. Concerning the total phenolic content of aqueous extract of silybum marianum, the result of our study indicates that, the plant extract had a high content of phenolic content. Previous studies reported the potent in vivo antioxidant activity of silybum marianum [59] . They attributed the in vivo antioxidant activity of silybum marianum due to the increase in the level of reduced glutathione, which is an important antioxidant that detoxifies drugs and chemicals. In addition, [60] reported that silybummarianum extract produces glutathione enhancer and liver regenerator effects. These authors attributed the protective effect of silybummarianum extract against hepatotoxicity induced by carbon tetrachloride are due to the antioxidant properties of flavonoids which present in the plant. Moreover, many previous investigations proved the potent in vitro antioxidant activity of silybum marianum plant extract such as those reported by [61] ; [14] and [62] .
